ABT
Price
$132.94
Change
+$0.13 (+0.10%)
Updated
Sep 5 closing price
Capitalization
231.38B
38 days until earnings call
STE
Price
$245.30
Change
+$1.91 (+0.78%)
Updated
Sep 5 closing price
Capitalization
24.16B
64 days until earnings call
Interact to see
Advertisement

ABT vs STE

Header iconABT vs STE Comparison
Open Charts ABT vs STEBanner chart's image
Abbott Laboratories
Price$132.94
Change+$0.13 (+0.10%)
Volume$3.29M
Capitalization231.38B
STERIS
Price$245.30
Change+$1.91 (+0.78%)
Volume$331.37K
Capitalization24.16B
ABT vs STE Comparison Chart in %
Loading...
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABT vs. STE commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Buy and STE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (ABT: $132.94 vs. STE: $245.30)
Brand notoriety: ABT: Notable vs. STE: Not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ABT: 52% vs. STE: 57%
Market capitalization -- ABT: $231.38B vs. STE: $24.16B
ABT [@Medical/Nursing Services] is valued at $231.38B. STE’s [@Medical/Nursing Services] market capitalization is $24.16B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABT’s FA Score shows that 2 FA rating(s) are green whileSTE’s FA Score has 0 green FA rating(s).

  • ABT’s FA Score: 2 green, 3 red.
  • STE’s FA Score: 0 green, 5 red.
According to our system of comparison, ABT is a better buy in the long-term than STE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABT’s TA Score shows that 5 TA indicator(s) are bullish while STE’s TA Score has 5 bullish TA indicator(s).

  • ABT’s TA Score: 5 bullish, 3 bearish.
  • STE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ABT is a better buy in the short-term than STE.

Price Growth

ABT (@Medical/Nursing Services) experienced а +0.21% price change this week, while STE (@Medical/Nursing Services) price change was +0.36% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.04%. For the same industry, the average monthly price growth was +4.21%, and the average quarterly price growth was +24.44%.

Reported Earning Dates

ABT is expected to report earnings on Oct 15, 2025.

STE is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Medical/Nursing Services (-0.04% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABT($231B) has a higher market cap than STE($24.2B). STE has higher P/E ratio than ABT: STE (37.51) vs ABT (16.68). STE YTD gains are higher at: 20.235 vs. ABT (19.228). ABT has higher annual earnings (EBITDA): 11.6B vs. STE (1.41B). STE has less debt than ABT: STE (2.07B) vs ABT (13.4B). ABT has higher revenues than STE: ABT (43.1B) vs STE (5.57B).
ABTSTEABT / STE
Capitalization231B24.2B955%
EBITDA11.6B1.41B824%
Gain YTD19.22820.23595%
P/E Ratio16.6837.5144%
Revenue43.1B5.57B774%
Total Cash7.28BN/A-
Total Debt13.4B2.07B648%
FUNDAMENTALS RATINGS
ABT vs STE: Fundamental Ratings
ABT
STE
OUTLOOK RATING
1..100
6435
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
66
Overvalued
PROFIT vs RISK RATING
1..100
4742
SMR RATING
1..100
3171
PRICE GROWTH RATING
1..100
5435
P/E GROWTH RATING
1..100
9564
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ABT's Valuation (18) in the Medical Specialties industry is somewhat better than the same rating for STE (66). This means that ABT’s stock grew somewhat faster than STE’s over the last 12 months.

STE's Profit vs Risk Rating (42) in the Medical Specialties industry is in the same range as ABT (47). This means that STE’s stock grew similarly to ABT’s over the last 12 months.

ABT's SMR Rating (31) in the Medical Specialties industry is somewhat better than the same rating for STE (71). This means that ABT’s stock grew somewhat faster than STE’s over the last 12 months.

STE's Price Growth Rating (35) in the Medical Specialties industry is in the same range as ABT (54). This means that STE’s stock grew similarly to ABT’s over the last 12 months.

STE's P/E Growth Rating (64) in the Medical Specialties industry is in the same range as ABT (95). This means that STE’s stock grew similarly to ABT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABTSTE
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
61%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
56%
Declines
ODDS (%)
Bearish Trend 10 days ago
51%
Bearish Trend 20 days ago
51%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
62%
Aroon
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 4 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
ABT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HFRO6.190.02
+0.32%
Highland Opportunities and Income Fund
XHYF38.080.10
+0.26%
BondBloxx US Hg Yld Fncl & REIT Str ETF
COWZ57.550.06
+0.10%
Pacer US Cash Cows 100 ETF
KMLM26.850.02
+0.06%
KraneShares Mount LucasMgdFutsIdxStgyETF
ABNY10.11-0.15
-1.43%
YieldMax ABNB Option Income Strategy ETF